Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421682
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421682
Neurological Biomarkers Market Share, Size, Trends, Industry Analysis Report, By Type (Metabolomic, Genomic, Imaging, Proteomic, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032
PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global neurological biomarkers market size is expected to reach USD 24.83 billion by 2032, according to a new study by Polaris Market Research. The report "Neurological Biomarkers Market Share, Size, Trends, Industry Analysis Report, By Type (Metabolomic, Genomic, Imaging, Proteomic, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Neurological biomarkers serve as indicators for measuring and assessing symptoms or determining a pharmacological response to a specific treatment. They find extensive application in the diagnosis of various conditions, including autism, Parkinson's disease, and depression. These biomarkers fall into several categories, including metabolomics, imaging, genomics, and proteomics.
Advancements in neurological biomarkers, encompassing signature biomarkers, are enhancing the effectiveness of treating neurological diseases, expediting drug development, enabling early diagnosis, and facilitating noninvasive testing. Furthermore, digital biomarkers are supplying valuable supplementary information to pharmaceutical companies, aiding in clinical trial decision-making and, consequently, propelling the growth of the neurological biomarkers market.
In the realm of personalized medicine, neurological biomarker research for neurodegenerative diseases represents a rapidly advancing field, with numerous molecules being associated and evaluated in the context of various neurodegenerative disorders. This evolution in precision medicine is significantly influencing the biopharmaceutical industry, leading to substantial transformations across various players, from biopharma to diagnostics companies, with roles ranging from commercial operations to research and development.
Even with this, the market's growth may be hindered by protracted biomarker development cycles and substantial startup costs. On a positive note, the presence of organizations offering funding at various research stages presents ample opportunities for market expansion. Notably, the National Institutes of Health (NIH) is allocating additional funds to support research related to health disparities in Alzheimer's and brain aging, further stimulating market growth.
Additionally, a study published in the National Library of Medicine in June 2021 highlighted the significant impact of coronary artery disease (CAD) on global health. CAD alone is responsible for approximately 610,000 deaths annually, accounting for an estimated one in four deaths and making it the foremost cause of mortality in the United States. With the incidence of CAD rising, there is a growing demand for effective Neurological Biomarkers devices to address this pressing medical need. Consequently, this factor is projected to drive the demand for Neurological Biomarkers throughout the forecast period.
Neurological Biomarkers Market Report Highlights
- In 2022, the Proteomic segment dominated with the highest revenue share. Proteomic biomarkers play a pivotal role, especially when relying solely on mRNA expression falls short in revealing the functional implications of diverse post-translational modifications. In such scenarios, proteomic biomarkers become indispensable for accurately diagnosing the onset and progression of diseases by meticulously detecting protein signatures and post-translational changes. These biomarkers have demonstrated remarkable effectiveness in unveiling the cellular alterations underlying complex and unexplained conditions like Alzheimer's disease (AD). Prominent proteomic biomarkers for AD include glial fibrillary acidic protein (GFAP), copper-zinc superoxide dismutase (SOD1), AB42, tau, and AB peptides. The continuous introduction of new products is expected to be a driving force behind market growth.
- Alzheimer's disease secured the largest market share in 2022 and is expected to continue its dominance during the forecast period. This trend is mainly driven by the rising prevalence of the disease and a heightened focus on early diagnosis and prompt treatment.
- In 2022, North America took the lead as the largest market. The neurological biomarkers market in North America holds a substantial share and is expected to exhibit a noteworthy CAGR in the upcoming forecast period. This growth is underpinned by several factors, including the high prevalence of neurological disorders and the surge in government initiatives aimed at supporting this sector. Moreover, the market is set to gain from a growing influx of new product launches and an increasing demand for biomarkers. The region maintains robust funding for research and the development of innovative biomarkers, further contributing to market advancement.
- The global key market players include: Abbott, Alseres Pharmaceuticals, Inc., BANYAN BIOMARKERS, INC., Bio-Rad Laboratories, Inc., DiaGenic ASA, Johnson & Johnson Services, Inc., Merck & Co., Inc., Myriad Genetics, Inc., Quanterix, Thermo Fisher Scientific, Inc.
Polaris Market Research has segmented the Neurological Biomarkers market report based on type, application, end-use, and region:
Neurological Biomarkers, Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Metabolomic
- Genomic
- Imaging
- Proteomic
- Others
Neurological Biomarkers, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Autism Spectrum Disorder
- Parkinson's Disease
- Alzheimer's Disease
- Multiple Sclerosis
- Others
Neurological Biomarkers, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)
- Independent clinical diagnostic centers
- Research Organizations and Others
- Hospital & Hospital Laboratories
Neurological Biomarkers, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM4022
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Neurological Biomarkers Market Insights
- 4.1. Neurological Biomarkers Market - Application Snapshot
- 4.2. Neurological Biomarkers Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Incidence of Neurological Disorders
- 4.2.1.2. Elevated investment in Research and Development (R&D) for biomarkers
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High initial investment expenses and lengthy biomarker development cycles
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Neurological Biomarkers Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Neurological Biomarkers Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 5.3. Metabolomic
- 5.3.1. Global Neurological Biomarkers Market, by Metabolomic, by Region, 2019-2032 (USD Billion)
- 5.4. Genomic
- 5.4.1. Global Neurological Biomarkers Market, by Genomic, by Region, 2019-2032 (USD Billion)
- 5.5. Imaging
- 5.5.1. Global Neurological Biomarkers Market, by Imaging, by Region, 2019-2032 (USD Billion)
- 5.6. Proteomic
- 5.6.1. Global Neurological Biomarkers Market, by Proteomic, by Region, 2019-2032 (USD Billion)
- 5.7. Others
- 5.7.1. Global Neurological Biomarkers Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Neurological Biomarkers Market, by End Use
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 6.3.Independent clinical diagnostic centers
- 6.3.1. Global Neurological Biomarkers Market, by Independent clinical diagnostic centers, by Region, 2019-2032 (USD Billion)
- 6.4. Research Organizations and Others
- 6.4.1. Global Neurological Biomarkers Market, by Research Organizations and Others, by Region, 2019-2032 (USD Billion)
- 6.5. Hospital & Hospital Laboratories
- 6.5.1. Global Neurological Biomarkers Market, by Hospital & Hospital Laboratories, by Region, 2019-2032 (USD Billion)
7. Global Neurological Biomarkers Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 7.3. Autism Spectrum Disorder
- 7.3.1. Global Neurological Biomarkers Market, by Autism Spectrum Disorder, By Region, 2019-2032 (USD Billion)
- 7.4. Parkinson's Disease
- 7.4.1. Global Neurological Biomarkers Market, by Parkinson's Disease, By Region, 2019-2032 (USD Billion)
- 7.5. Alzheimer's Disease
- 7.5.1. Global Neurological Biomarkers Market, by Alzheimer's Disease, By Region, 2019-2032 (USD Billion)
- 7.6. Multiple Sclerosis
- 7.6.1. Global Neurological Biomarkers Market, by Multiple Sclerosis, By Region, 2019-2032 (USD Billion)
- 7.7. Others
- 7.7.1. Global Neurological Biomarkers Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Neurological Biomarkers Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Neurological Biomarkers Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Neurological Biomarkers Market - North America
- 8.3.1. North America: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.3.2. North America: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.3.3. North America: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.3.4. Neurological Biomarkers Market - U.S.
- 8.3.4.1. U.S.: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.3.5. Neurological Biomarkers Market - Canada
- 8.3.5.1. Canada: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.4. Neurological Biomarkers Market - Europe
- 8.4.1. Europe: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.4.3. Europe: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.4.4. Neurological Biomarkers Market - UK
- 8.4.4.1. UK: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.4.5. Neurological Biomarkers Market - France
- 8.4.5.1. France: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.4.5.3. France: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.4.6. Neurological Biomarkers Market - Germany
- 8.4.6.1. Germany: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.4.7. Neurological Biomarkers Market - Italy
- 8.4.7.1. Italy: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.4.8. Neurological Biomarkers Market - Spain
- 8.4.8.1. Spain: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.4.9. Neurological Biomarkers Market - Netherlands
- 8.4.9.1. Netherlands: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.4.10. Neurological Biomarkers Market - Russia
- 8.4.10.1. Russia: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.5. Neurological Biomarkers Market - Asia Pacific
- 8.5.1. Asia Pacific: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.5.4. Neurological Biomarkers Market - China
- 8.5.4.1. China: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.5.4.3. China: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.5.5. Neurological Biomarkers Market - India
- 8.5.5.1. India: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.5.5.3. India: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.5.6. Neurological Biomarkers Market - Malaysia
- 8.5.6.1. Malaysia: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.5.7. Neurological Biomarkers Market - Japan
- 8.5.7.1. Japan: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.5.8. Neurological Biomarkers Market - Indonesia
- 8.5.8.1. Indonesia: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.5.9. Neurological Biomarkers Market - South Korea
- 8.5.9.1. South Korea: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.6. Neurological Biomarkers Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.6.4. Neurological Biomarkers Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.6.5. Neurological Biomarkers Market - UAE
- 8.6.5.1. UAE: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.6.6. Neurological Biomarkers Market - Israel
- 8.6.6.1. Israel: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.6.7. Neurological Biomarkers Market - South Africa
- 8.6.7.1. South Africa: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.7. Neurological Biomarkers Market - Latin America
- 8.7.1. Latin America: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.7.4. Neurological Biomarkers Market - Mexico
- 8.7.4.1. Mexico: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.7.5. Neurological Biomarkers Market - Brazil
- 8.7.5.1. Brazil: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- 8.7.6. Neurological Biomarkers Market - Argentina
- 8.7.6.1. Argentina: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Alseres Pharmaceuticals, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. BANYAN BIOMARKERS, INC.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Bio-Rad Laboratories, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. DiaGenic ASA
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Johnson & Johnson Services, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Merck & Co., Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Myriad Genetics, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Quanterix
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Thermo Fisher Scientific, Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
Product Code: PM4022
List of Tables
- Table 1 Global Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 2 Global Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 3 Global Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 4 Neurological Biomarkers Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 5 North America: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 6 North America: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 7 North America: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 8 U.S.: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 9 U.S.: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 10 U.S.: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 11 Canada: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 12 Canada: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 13 Canada: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 14 Europe: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 15 Europe: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 16 Europe: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 17 UK: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 18 UK: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 19 UK: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 20 France: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 21 France: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 22 France: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 23 Germany: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 24 Germany: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 25 Germany: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 26 Italy: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 27 Italy: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 28 Italy: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 29 Spain: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 30 Spain: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 31 Spain: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 32 Netherlands: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 33 Netherlands: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 34 Netherlands: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 35 Russia: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 36 Russia: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 37 Russia: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 38 Asia Pacific: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 39 Asia Pacific: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 40 Asia Pacific: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 41 China: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 42 China: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 43 China: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 44 India: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 45 India: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 46 India: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 47 Malaysia: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 48 Malaysia: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 49 Malaysia: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 50 Japan: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 51 Japan: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 52 Japan: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 53 Indonesia: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 54 Indonesia: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 55 Indonesia: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 56 South Korea: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 57 South Korea: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 58 South Korea: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 59 Middle East & Africa: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 60 Middle East & Africa: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 61 Middle East & Africa: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 62 Saudi Arabia: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 63 Saudi Arabia: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 64 Saudi Arabia: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 65 UAE: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 66 UAE: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 67 UAE: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 68 Israel: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 69 Israel: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 70 Israel: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 71 South Africa: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 72 South Africa: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 73 South Africa: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 74 Latin America: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 75 Latin America: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 76 Latin America: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 77 Mexico: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 78 Mexico: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 79 Mexico: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 80 Brazil: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 81 Brazil: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 82 Brazil: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
- Table 83 Argentina: Neurological Biomarkers Market, by Type, 2019-2032 (USD Billion)
- Table 84 Argentina: Neurological Biomarkers Market, by End Use, 2019-2032 (USD Billion)
- Table 85 Argentina: Neurological Biomarkers Market, by Application, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Neurological Biomarkers Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by End Use
- Figure 7. Global Neurological Biomarkers Market, by End Use, 2022 & 2032 (USD Billion)
- Figure 8. Market by Type
- Figure 9. Global Neurological Biomarkers Market, by Type, 2022 & 2032 (USD Billion)
- Figure 10. Market by Application
- Figure 11. Global Neurological Biomarkers Market, by Application, 2022 & 2032 (USD Billion)
- Figure 12. Neurological Biomarkers Market Assessment, By Geography, 2019-2032 (USD Billion)
- Figure 13. Strategic Analysis - Neurological Biomarkers Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.